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AND CLARENCE S. LIVINGOOD, M.D.
With the technical assistance of Marlene A. Baker
Despite many studies on staphylocoecal
infections in the surgical patient, the medical
patient, and the infant, there is a dearth of
bacteriological data on dermatological patients,
especially in-patients. This paper presents
representative bacteriological data on some of
the out-patients and in-patients treated in this
department during the period 1955—1960. The
antibiograms and phage types of strains of
Staphylococcu.s aureu.s are listed and correlated
with the diagnoses of the patients and sites from
which the strains were isolated.
The number of recent reports concerning
staphylococcal infections or S. aureus now
exceeds 800. Since the essence of these reports
may be found in four recent publications of the
U. S. Public Health Service (1), a review is
omitted here.
METHODS
The laboratory methods used are those de-
scribed previously (2, 3). The phages used and
their arrangement into groups are shown in Table
I. They include the 21 basic phages recommended
by the International Subcommittee on Staphylo-
coccal Phage Typing of the International Commit-
tee on Bacteriological Nomenclature of the In-
ternational Association of Microbiologists, plus
3 additional phages. All 24, and their propagating
strains, were kindly supplied by Dr. John E. Blair,
Hospital for Joint Diseases, New York City. The
typing procedures used were slight modifications
of the methods described by Blair and Carr (4)
and Williams and Rippon (5).
The five antibiotics employed for the antibio-
grams reported here are streptomycin, penicillin,
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erythromycin, chioramphenicol, and tetracycline,
although as many as nine additional antimicrobial
agents were used at times. The numerical designa-
tion of antibiograms previously reported (6, 7)
was employed. Both tube (broth) dilution and
disc (agar diffusion) technics for antibiotic sus-
ceptibility were employed. The latter was used
more frequently as correlation has continued to
be excellent. This resulted from careful attention
to conditions of the test, and especially to inter-
pretation of results. The broth dilution tests were
performed as described previously (8), but data
on replicate strains from the same person were
excluded. The antibiotics and the concentrations
used are shown in Table II. The multiple tube
dilution method, in which individual but large
amounts of the antibiotic concentrations are made
and multiple tubes filled from these, was used
in lieu of the serial dilution method. Thus the
amount of antibiotic in each tube can be selected
without each being twice the amount in the follow-
ing tube.
The Dermatology Research Laboratory is an
integral part of this Department and bacterio-
logical as well as clinical data are therefore
maintained within the Department. Alpha-
betically-arranged summary sheets of all bac-
teriological data and concurrent clinical synopses
on patients are kept by the laboratory. In addi-
tion, these data are transcribed to data processing
cards on which is punched the following coded
information: the name of the person from whom
the strain was isolated; his status as a patient,
or as part of the staphylococcus carrier survey;
the year, and its season (quarter); the antibiotic
susceptibility or resistance to as many as 14
antibiotics; the in-patient, or out-patient status
of the patient; the primary and secondary
diagnoses; the site from which culture was made;
the reaction (weak or strong) to each of the 24
phages; the number of lysing phages; the group
or groups of the lysing phages; and the occurrence
of other pathogens, such as beta hemolytic
streptococci, in addition to pathogenic staph-
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ylococci. A card is made to represent each
different strain isolated from every culture.
All patients with adequate clinical and labora-
tory data, and from whom S. aureus was isolated,
are included in this report. The data were first
compiled for each of the calendar years, 1955—
1958, and the first quarter of 1959. Only one
strain, representing a different antibiogram
and/or phage type, from each person was in-
cluded, the rest being discarded as replicates.
These representative strains were then sorted
and tabulated according to autibiograms, as
shown in Table III.
Since phage typing was a procedure added
recently, the period, April 1, 1959 through
March 31, 1960, was selected as a sample year
for which phage types and antibiograms of the
staphylococci could be studied with respect to
the sites and diagnoses of the patients from whom
they were isolated. This was done by first separat-
ing all the data cards for strains isolated during
these four quarters. Grouping was again made of
all strains from each patient. Only strains from
TABLE I
Groups of the J4 Phages Used in This Study
I 29 52 52A 79 80
II 3A 3B 30 55 71
III 6
54
7
73
42E
75
47
77
53
83*
IV 42D
V 187
Miscellaneous 44A* 81*
* Phages in addition to the International Set.
out-patients, or from in-patients with admission
cultures taken before exposure to the hospital
environment, were included. Replicates were
also discarded, as mentioned above, except that
instead of selecting only one strain of each kind
from any one person, duplicates were included
if one was from the nares and the other from a
skin lesion. No strains from normal skin were
included. The representative strains were then
sorted and tabulated according to diagnoses and
sites, as shown in Table IV. Further classification
of the data for this sample year was then made
according to diagnoses, sites, antibiograms, and
phage types, as shown in Table V. The totals of
the antibiogram data for the sample year (last 3
quarters of 1959, and first quarter of 1960) were
then included in Table III. Since strains from
patients with the miscellaneous diagnoses listed
in Table IV were relatively small in number and
quite similar, they have been grouped together
in Table V under Other Diagnoses. The phage
typing data have been tabulated according to
the groups shown in Table I.
Some strains were lysed by one or more phages
of Group I as well as 80/81, but were counted as
80/81 strains in Table V. Nontypable (NT)
strains were those not lysed by any phage used
at its routine or critical test dilution.
A group of 234 out-patients, from whom S.
aureus was isolated during 1959—1960 in siniul-
taneous cultures from shin lesions and nares, was
also studied. Tabulations were made according
to the classifications shown in Table VI. Strains
were considered different if either the phage type
or antibiogram was different.
TABLE II
Minimum Inhibitory Concentration in Broth Dilution of 8 Antibiotics for 70 Different Strains of Staph.
aureus isolated from 54 patients
No. of
Strains
Minimum Inhibitory Concentration, Lg./m1. or units/mi.
————-— ——
0.1 0.25 0.5 1.0 2.5 S 10 25 R25*
Bacitracin
Chlorampenicol
Erythromycin
Neomycin
Novobiocin
Penicillin
Oxytetracycline
Tetracycline
48
7
29
48
48
29
29
7
1
10
9
5
1
29
1
8
1
21
6
13
5
10
1
2
8
34
26
1
4
1
13
6
10
3 4
1
8
6
2
* These numbers represent those staphylococci resistant to 25 units or Lg./ml.
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TABLE III
Frequency of Antibio grams of Pd545 Different Strains of Staph. aureus Isolated from t016
Patients During 1955—1960
Antibiogram 1955 1956 1957 1958 1st Quarter 1959—1960
0
S 0
C 0
SC 0
SE 0
SPC 0
28 52%
3 6%
1 2%
11 3%
156 42%
1
131 35%
17 5%
116 17%
3
165 24%
84 41% 307 36%
2
S 2
C 2
sc 2
ST 2
EC 2
SEC 2
7 13%
1
1
1
11 3%
103 27%
1
1
115 30%
98 14%
1
134 19%
62 31% 302 36%
25
S 25
C 25
SC 25
SEC 25
7 13% 10 3%
54 15%
1
1
56 15%
3
21 3%
19 3%
1
19 9% 55 6%
125
C 125
2 4% 4
19 5%
29 4%
49 7%
24 12% 102 12%
1235
C 1235
1 2
3
15 2%
3
6 3% 29 3%
5
S 5
SC 5SPC 5
2 4%
11 3% 7
7
5
13 2%
3 11 1%
12
C 12
6
1
11 1%
235
C 235
Sc 235 9 2% 5
1
8
4
135
15
1 2
1
1
2
1
1
5
6
6
23
SC 23
35
SPC 35
1
2
1
1 3
1
TABLE 111—Continued
Antibiograin 1955 1956 1957 1958 1st Qarter 1959—196O
1
12345
1245
2345
1
1
1
1
2
1
1
45
24
123 1
1
1
13
3
245 1
1
1
No. of Patients
No. of Strains
40
54
294
369
340
378
)3
689
163
206
576
849
* Includes only out-patient strains. Other periods include strains from both out- and in-patients.
TABLE IV
Fsequency Distribution, According to Diagnoses, of 849 Strains of Staph. a'ureus Isolated from
576 Dermatological Out-Patients Seen from April 1, 1959, through March 31, 1960
Diagnoses No. Patients
Number of Strains
From nares From lesions Total
Furunculosis 149 79 157 236
Eczematous Dermatitis 108 28 128 156
Atopic Dermatitis 54 36 66 102
Impetigo 48 10 50 60
Miscellaneous, including:
Acne 18 17 6 23
Contact Dermatitis 21 5 22 27
Stasis Dermatitis 27 12 23 35
Bullous Eruptions 10 10 9 19
Seborrheic Dermatitis 11 4 10 14
Pustular Folliculitis 13 5 9 14
Nummular Eczema 1 1 1 2
Tinea 10 2 12 14
Hidradenitis suppurativa 12 4 14 18
Psoriasis 6 6 3 9
Neurodermatitis 3 2 4 6
Erysipelas 1 1 0 1
Lymphedema 4 4 0 4
Mycosis fungoides 1 1 0 1
Thrombophiebitis 5 5 2 7
Lupus erythematosus 2 1 1 2
Post-operative infections 11 0 12 12
Candidiasis 2 0 2 2
Neurotic excoriations 3 0 4 4
Abscess 5 0 5 5
Otitis externa 2 0 2 2
Other Diagnoses 49 18 56 74
576 251 598 849
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TABLE V
Antibiograms and Phage Types of 849 Strains of Staph. aureus Isolated from 576
Derniatological Out-Patients in One Year (April 1, 1959—March 31, 1960)
Diagnosis and Site
Antibiograms
0 2 25 125 Other Total
Phage Types and Groups
80/81 I H III NTt Total
Furunculosis
Nares 20
25%
16
20%
11
15%
18
23%
14
18%
79
100%
30
50%
7
12%
5
8%
8
13%
9
15%
1
2%
60
100%
Lesion 29
18%
35
22%
26
17%
42
27%
25
16%
157
100%
70
61%
5
4%
6
5%
7
6%
10
9%
17
15%
115
100%
Ecz. Dermatitis
Nares 11%
39%
11%
39%
0
0
1
4%
5
18%
28
100%
1
4%
1
4%
2
7%
10
37%
2
7%
11
41%
27
100%
Lesion 51
40%
54
42%
3
2%
9
7%
11
9%
128
100%
5
7%
5
7%
3
4%
27
4A%
4
6%
25
37%
68
101%
Atopic Dermatitis
Nares 14
39%
17
47%
1
3%
1
3%
3
8%
36
100%
2
6%
3
9%
2
6%
11
32%
2
6%
14
41%
34
100%
Lesion 18
27%
36
54%
6
9%
3
5%
3
5%
66
100%
5
11%
1
2%
5
11%
15
33%
1
2%
18
40%
45
99%
Impetigo
Nares 5
50%
3
30%
0 1
10%
1
10%
10
100%
0 3
33%
1
11%
2
22%
1
11%
2
22%
9
99%
Lesion 33
66%
12
24%
1
2%
3
6%
1
2%
50
100%
2
13%
1
7%
5
33%
3
20%
2
13%
2
13%
15
99%
Other Diagnoses
Nares 43
44%
38
39%
2
2%
8
8%
7
7%
98
100%
6
7%
13
15%
4
5%
20
23%
14
16%
31
35%
88
101%
Lesion 83
42%
78
40%
5
3%
18
9%
13
7%
197
101%t
19
14%
16
12%
9
7%
31
23%
20
15%
39
28%
134
99%
* Mixed (not classified) groups and miscellaneous patterns of lysis, including Groups IV and V.
t Not typable.
Percentages have been rounded to the nearest integer, thus some totals do not equal 100.
§ Includes those listed in Table IV.
Some in-patients were also studied in a series
of 154 consecutive hospital admissions to the
Dermatology Service during the period of August
1 to December 5, 1959. Cultures were taken at
the time of admission and periodically thereafter
from the flares and lesions of these patients. If
no lesions were present, cultures were taken from
several areas of normal skin, such as the axilla
and groin. The diagnoses of these patients in-
cluded eczematous dermatitis of the hands and
feet, atopic dermatitis, exfoliative dermatitis,
stasis dermatitis and/or stasis ulcers, pemphigus,
dermatitis herpetiformis, psoriasis, lupus ery-
thematosus, lymphedema due to various causes,
and miscellaneous dermatoses.
RESULTS
The minimum inhibitory concentrations in
broth dilutions of 8 antibiotics for 70 strains
from 54 patients are shown in Table II. For the
antibiotic susceptible strains tested, these anti-
biotics may be listed in order of effectiveness on
a weight basis as follows: penicillin, novobiocin,
tetracycline, oxytetracycline, erythromycin, neo-
mycin, chloramphenicol and bacitracin. Data
based on more than half the entire number of
strains were replicates and deleted to avoid bias
by multiple strains from one person. These were
almost identical, and results with the disc proce-
dure were also in agreement.
The antibiograms of 2545 different strains of
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TABLE VI
Source of Staph. aureus in Simultaneous Cultures
from Nares and Skin Lesions of P134 Out-
Patients of Dermatology Clinic (1959—1960)
S. aureus Isolated From No. of Patients
A. 61 patients with furunculosis
Nares only
Skin lesions only
Both nares and skin lesions
(Same strain, both sites)
(Different strain, each site)
0
21 (34%)
40 (66%)
33 (54%)
7 (12%)
B. 173 patients with diagnoses other than
furunculosis from whom Staph. aureus
was isolated
Nares only 36 (21%)
Skin lesions only 30 (17%)
Both nares and skin lesions 107 (62%)
(Same strain, both sites) 80 (46%)
(Different strain, each site) 12 (7%)
(Same on one date, different an- 15 (9%)
other)
S. aureus isolated from 2016 patients during
1955—1960 are listed in Table III. Most of the
strains in the entire period were penicillin resist-
ant. Except for the small number of strains in
1955, approximately 40% have been susceptible
to penicillin, with 30% resistant to penicillin
only. The shift in percentages from those resistant
to penicillin and tetracycline (Abg 25) to those
resistant to streptomycin, peniciffin and tetracy-
cline (Abg 125) is due to the omission of routine
testing for streptomycin susceptibility until late
in 1957. Routine ehloramphenieol susceptibility
testing was omitted until 1958. There is no
evidence in these data that the percentage of
resistant strains was increasing annually.
The frequency distribution, according to
diagnosis, of the strains from out-patients is
given in Table IV. Some patients had a different
diagnosis at different times; some had multiple
diagnoses simultaneously. Strains from such
patients were classified according to the present-
ing diagnosis, whenever possible; otherwise
these were listed with the miscellaneous strains
under "Other Diagnoses." The number of strains
from the nares is usually less than the number of
patients with each diagnosis, since S. aureus
was not always isolated from the nares. However,
two or more strains were frequently isolated from
the same site, nares or lesion, hence the number
of strains from lesions is usually greater than the
number of patients.
The tabulation of antibiograms and phage
types of the strains of S. aureus isolated from
out-patients in the year April 1, 1959—March
31, 1960, is given in Table V. Strains isolated
from patients with furunculosis differed from
those from patients with other diagnoses in that
the furuneulosis strains were more antibiotic
resistant. Only about half as many strains from
patients with furunculosis were antibiotic
susceptible, or resistant to penicillin only, as
were those from patients with other diseases.
The data on impetigo are meager, but have been
listed separately since this is one of the important
primary cutaneous bacterial infections. The
percentages of organisms with various anti-
biograms were similar for nasal and lesion strains
regardless of diagnosis.
The furunculosis strains also differed from
others in their phage group distribution. Mo:re
furunculosis strains were lysed by 80/81, or by
some of Group I, whereas those from other
diagnoses had a higher percentage of strains
lysed by one or more phages of Group III. The
percentage of nontypable strains was also lower
in furuneulosis than in other diagnoses. No
difference in the distribution of strains lysed by
Group II phages was apparent according to
various diagnoses. Nasal and lesion strains were
also similar in phage group distributions as they
were for their susceptibility to antibiotics.
However, the data in Table VI show that, of
these 234 out-patients having S. aureus and
having simultaneous cultures from skin lesions
and flares, only about two thirds had S. aureus
in both sites. Furthermore, of all these 234
patients, only half had organisms of the same
antihiogram and phage type in both sites. Of
the 61 patients with furunculosis, 82.5% (33 of
40) who had S. aureus in both sites had the same
organism. Of the 173 patients with other diag-
noses 75% (80 of 107) who had S. aureus in
both sites, had the same organism. This difference
(7.5%) is less than twice the standard error.
Similar data are tabulated in Table VII. In
only 66% of these patients was S. aureus isolated
on admission to the hospital. About half (58%) of
those having S. aureus had it in both sites, and
in 86%, organisms from both sites had the same
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TABLE VII
Incidence of Staph. aureus Isolated from Nares and
Skin Lesions of 154 In-Patients Admitted Con-
secutively to Dermatology Service, August 1
through December 5, 1959
Siaph. aureus Isolated From: No. of Patients
Nares only 25 (16%)
Skin lesions only* 18 (12%)
Both flares and skin lesions 59 (38%)
(Same strain, both sites) 51 (29%)
(Different strain, each site) 8 (9%)
Neither nares nor skin lesions 52 (34%)
* In patients with no open skin lesions (e.g.
lymphedema of the extremities), cultures were
taken from normal skin at several sites.
antibiogram and phage type. In 16, or about
10% of the 154 patients, the strain isolated on
admission differed in phage type and/or anti-
biogram from that isolated subsequently. In eight
strains the change was from antibiotic resistance
to susceptibility (Abg 0), or to normal flora. In
the other eight, the reverse was true. Only two
patients developed clinical infection, viz., furun-
culosis. Subsequent to hospitalization, both
patients acquired strains resistant to strepto-
mycin, penicillin, and tetracycline (Abg 125),
phage type 80/81. In one of these patients, the
course of furunculosis was very prolonged, but
both patients recovered.
When the percentage of patients in Table VI
(77%) with the same organism, under these
conditions, is compared with those in Table VII
(86%), the difference (9%) is less than twice the
standard error. This does not include the 15
patients who had the same strains in both sites
on one date but not on another. If these 15 are
counted as having the same strain in both sites,
the percentages for these groups are 87% and
86%, respectively.
COMMENT
The data in Table II are extensions of those
presented previously (9). More strains have been
tested, and the replicate strains from the same
person deleted. Nevertheless, the adjusted data
here presented in Table II are quite similar to
the data in Table II of the previous paper (9).
At that time no strains completely resistant to
either novobiocin or neomycin had been observed,
and only a few (26 of 2135 and 3 of 2355) were
moderately resistant. No increase in resistance
to these has been observed. Although neomycin
was inferior on a weight basis, to all except
chioramphenicol and bacitracin, it completely
inhibited a larger number of strains of S. aureus
than any other antibiotic used during the five
year period.
As shown in Table III, there has been no
annual increase in antibiotic resistant strains in
the out-patient group. Another five year study
(10) has likewise failed to show the general
population to be a reservoir of antibiotic resistant
staphylococci.
The data in Table VII are based on some
dermatological patients hospitalized for treat-
ment. One would not expect their staphylococcal
epidemiology to resemble that of other types of
in-patients, especially those receiving domiciliary
care or those chronically ill. Indeed, as Tables
VI and VII show, the results are similar for the
out-patients and in-patients we studied, since
the results in Table VII are for cultures taken on
admission to the hospital. But, most (about 90%)
of these in-patients had staphylococci during
hospitalization and on discharge which were
indistinguishable from those isolated on admis-
sion. Further details on this group of patients is
to be published elsewhere.
The data of Tulloch (11) on the identity of
strains from nares and skin lesions arc similar to
those presented in Tables VI and VII. His 73
patients had "pairs of cultures", but he failed to
mention how many other patients did not have
S. aureus in both sites. It must be emphasized,
however, that Table VI includes data only on
patients from whom S. aureus was isolated,
whereas Table VII includes 34% from whom it
was never isolated. Of the patients described in
Table VII, 62% did not have S. aureus in both
sites. Therefore, "sterilization of the anterior
flares", which he stressed as a "corollary to
other methods of treatment", would possibly be
ineffective for many people. Similar, but much
smaller, studies on nasal and cutaneous lesion
strains have been reported by others such as
Valentine and Hall-Smith (12) and Roodyn (13).
Literature on the problem of management of
carriers has been reviewed by Martin, Nichols,
and Henderson (14). Their experience with
various methods of reducing the nasal carrier
state, as well as using no treatment, indicated
none was very effective.
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Koch et at. (15) reported that of 72 strains
from "boils, abscesses, carbuncles, and ulcers,"
53 were phage type 80/81. These 53 from such
infections represented 48% of the entire 110
type 80/81 strains they isolated. No impetigo
was encountered in their patients at a Veterans
Administration Center, but Parker, Tomlinson,
and Williams (16) and Spittlehouse (17) reported
impetigo strains in their studies were lysed
predominately by phage 71 of Group II. Our
meager data on impetigo preclude comparison.
A very interesting and related, but more
extensive, study has recently been reported from
Australia (18). The results of this survey of
cutaneous and subcutaneous infections are
similar to ours in the following respects: (1) the
high incidence, about 60%, of strains resistant
to penicillin, (2) the low incidence of strains
multiply resistant to antibiotics, (3) the high
incidence of phage type 80/8 1 strains in furun-
culosis, and its low incidence in impetigo, (4)
the low incidence of nasal carriage of staph-
ylococci, and (5) the very low incidence of
fatalities, one in their series, none in ours. In
contrast, our data show more tetracycline resist-
ant organisms, approximately 20—25% as
opposed to 4.2%. In furunculosis, the percentage
is higher (approximately 40%), but with other
diagnoses it is very low, resembling the Australian
data. Although their technic of antibiotic
susceptibility testing differed somewhat from
ours, we have had sufficient experience with
their technique to be certain that the difference
in tetracycline resistance is real and not the
result of technique or interpretation. Their
study was involved essentially with out-patients,
and very few had any hospital contact. There
were fewer multiply resistant strains than in our
data, although the percentage is low in both.
SUMMARY
Some representative bacteriological data are
presented on strains of S. aureus isolated from
dermatological patients treated during the
period 1955—1960. These data differ from those
of most laboratory reports in that correlation of
clinical and epidemiological information per-
mitted deletion of data on replicate strains from
the same patient.
The minimum inhibitory concentration of S
antibiotics in broth was determined for 70
different strains from 54 patients. Results with
the disc technic agreed. For susceptible or-
ganisms, the order of effectiveness of the anti-
biotics on a weight basis was penicillin,
novobiocin, tetracycline, oxytetracydine, ery-
thromycin, neomycin, chloramphenicol, and
bacitracin. Nevertheless, neomyein completely
inhibited more strains than any other antibiotic
tested in this five year period.
Of 2545 different strains from 2016 patients,
about 60% were resistant to penicillin, with
about 30% resistant to penicillin only. Approxi-
mately 20% were resistant to tetracycline; more
than half of these were resistant to streptomycin
as well.
No increase in the percentage of antibiotic
resistant strains isolated annually was observed.
For a sample year (1959—1960), 849 strains from
576 patients were classified according to anti-
biogram, phage type, and source, including
diagnoses of the patients and sites from which
the strains were isolated. Strains from patients
with furunculosis differed in their percentage
distributions of both antibiograms and phage
types from those strains from patients with
other diagnoses.
For each diagnosis the percentage distributions
of antibiograms and phage types of nasal strains
resembled those from lesions.
Furunculosis strains were characterized by
(1) a higher percentage of phage type 80/8 1 and
types within Group I, (2) a higher percentage of
antibiograms denoting resistance, and (3) a lower
percentage, about half as many, not lysed by
any phage.
Strains from diagnoses other than furunculosis
were characterized by (1) a higher percentage of
phage types within Group III, (2) a higher
percentage of antibiograms denoting suscepti-
bility to all or most of the 5 antibiotics tested,
and (3) a higher percentage, twice as many, not
lysed by any phage.
Of 234 out-patients having S. aureus in either
the flares or lesions, only about two thirds had it
in both sites and about half had strains with the
same antibiogram and phage type in both nares
and lesion. In other words, of those with S.
aureus in both nares and lesions, about four
fifths had identical strains in both sites. This
relationship was irrespective of diagnosis.
Cultures were taken from another group of
dermatological patients on their admission to the
hospital and repeated subsequently until dis-
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charge. About 10% (16 of 154) acquired strains
with antibiograms or phage types differing from
those isolated on admission. Only two patients
developed clinical infections, viz. furunculosis,
subsequent to hospitalization.
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DISCUSSION
Dn. RUTH M. HOTZ (Cincinnati General
Hospital, Cincinnati, Ohio): Were these all pure
cultures from these lesions? You have data on
the strep?
Dn. STEPHEN ROTHMAN (Chicago, Ill.): How
do the in vitro testings correlate with clinical
experience? If furuncles are caused by staph.
which is resistant to a certain antibiotic, is this
antibiotic always ineffective in clinical therapy?
In my experience, the correlation is not very
good.
DR. RICHARD B. STOUGHTON (Cleveland,
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Ohio): Was type 80-81 usually resistant to all
antibiotics?
DR. HARVEY BLANK (Miami, Florida): I
would like to add a confirmatory note from
studies by Dr. Joel Ehrenkranz of the University
of Miami, who has been studying furuneulosis
and impetigo in families in their homes. Furun-
culosis has been mostly 80-81, but impetigo has
been mostly non-80-81 type. It suggests that
among the staphylococci there are really different
organisms, one of which reminds me of the old
term impetigococcus used for certain strains of
staphylococcus. Perhaps we ought to revive
"impetigococcus" for the non-80-81, the non-
furuncle-causing staphylococci. The present
figures also agree with the findings in Miami of a
disparity between the nose cultures and the
lesion cultures and the normal skin cultures. The
old idea that the entire skin surface and nose
were always colonized by the same organism as
that causing an infectious lesion of the skin
apparently is not true, if I interpreted your
figures correctly. We, too, have discarded the
idea that a film of pathogenic bacteria covers the
body and mucous membranes in the presence of
frank pyogenic infection at one site. Would you
comment?
DR. JAMES E. GREER (in closing): In reply to
those who asked questions, I wish to thank them
for their interest.
Dr. Hotz, the organisms from the lesions, of
course, were not always isolated in pure culture.
Frequently, streptococci as well as more than
one strain of staphylococcus was isolated simul-
taneously from a single lesion. We do have data
on streptococci, which we plan to report later,
In answer to Dr. Rothman's question, this is
something I know he is very interested in, and
we hope to get some data on this, but it is very
difficult to evaluate. I cannot give you a clinical
statement, of course, with respect to the re-
sponse of patients and its correlation with
laboratory results.
With regard to the correlation of antibiograms
with phage types, there is some variation. Not
all 80/81's are of the same antibiogram, but
most of them have been Abg 125, that is, or-
ganisms resistant to streptomycin, penicillin, and
tetracycline.
In reply to Dr. Blank, we also have done a
family study. We have studied 28 family con-
tacts of patients with furunculosis, in 15 families.
The antibiograms and phage types of strains
were similar from both contacts and patients
with furunculosis, within families.
